Point72 Europe »

Vanda Pharmaceuticals shares owned by Point72 Europe

Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by Point72 Europe from 13F filings

Historical chart of Point72 Europe investment in Vanda Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vanda Pharmaceuticals held by Point72 Europe consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanda Pharmaceuticals by Point72 Europe

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2k 245 4.99

More positions owned by Point72 Europe

Strategy Cl A New (MSTR)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Capital One Financial (COF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Key (KEY)
Charles Schwab Corporation (SCHW)
TPG Com Cl A (TPG)
WESCO International (WCC)
Bank of America Corporation (BAC)
Regeneron Pharmaceuticals (REGN)
Suncor Energy (SU)
Linde SHS (LIN)

View all positions for Point72 Europe

Top funds holding Vanda Pharmaceuticals

BlackRock
Vanguard Group
Renaissance Technologies
Millennium Management
Dimensional Fund Advisors
Tang Capital Management
Acadian Asset Management
Geode Capital Management
State Street Corporation
Krensavage Asset Management
Two Sigma Advisers
Connor, Clark & Lunn Investment Management
Morgan Stanley
Empire Financial Management Company
Federated Investors

View all funds holding Vanda Pharmaceuticals